173 related articles for article (PubMed ID: 22877565)
41. Nur77 decreases atherosclerosis progression in apoE(-/-) mice fed a high-fat/high-cholesterol diet.
Hu YW; Zhang P; Yang JY; Huang JL; Ma X; Li SF; Zhao JY; Hu YR; Wang YC; Gao JJ; Sha YH; Zheng L; Wang Q
PLoS One; 2014; 9(1):e87313. PubMed ID: 24498071
[TBL] [Abstract][Full Text] [Related]
42. Orphan nuclear receptor TR3/Nur77 biologics inhibit tumor growth by targeting angiogenesis and tumor cells.
Chen C; Li Y; Hou S; Bourbon PM; Qin L; Zhao K; Ye T; Zhao D; Zeng H
Microvasc Res; 2020 Mar; 128():103934. PubMed ID: 31654655
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein M regulates the orphan nuclear receptor LRH-1 gene expression through binding to its promoter region in HepG2 cells.
Pan Y; Zhou HG; Zhou H; Hu M; Tang LJ
Drug Des Devel Ther; 2015; 9():2375-82. PubMed ID: 25987835
[TBL] [Abstract][Full Text] [Related]
44. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis.
Hamers AA; Vos M; Rassam F; Marinković G; Kurakula K; van Gorp PJ; de Winther MP; Gijbels MJ; de Waard V; de Vries CJ
Circ Res; 2012 Feb; 110(3):428-38. PubMed ID: 22194623
[TBL] [Abstract][Full Text] [Related]
45. ApoM: gene regulation and effects on HDL metabolism.
Nielsen LB; Christoffersen C; Ahnström J; Dahlbäck B
Trends Endocrinol Metab; 2009 Mar; 20(2):66-71. PubMed ID: 19200746
[TBL] [Abstract][Full Text] [Related]
46. Nuclear receptor Nur77 suppresses inflammatory response dependent on COX-2 in macrophages induced by oxLDL.
Shao Q; Shen LH; Hu LH; Pu J; Qi MY; Li WQ; Tian FJ; Jing Q; He B
J Mol Cell Cardiol; 2010 Aug; 49(2):304-11. PubMed ID: 20381497
[TBL] [Abstract][Full Text] [Related]
47. Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro.
Zhang X; Zhu Z; Luo G; Zheng L; Nilsson-Ehle P; Xu N
Biochem Biophys Res Commun; 2008 Jun; 371(1):114-7. PubMed ID: 18413148
[TBL] [Abstract][Full Text] [Related]
48. Palmitic acid suppresses apolipoprotein M gene expression via the pathway of PPARβ/δ in HepG2 cells.
Luo G; Shi Y; Zhang J; Mu Q; Qin L; Zheng L; Feng Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Biochem Biophys Res Commun; 2014 Feb; 445(1):203-7. PubMed ID: 24508264
[TBL] [Abstract][Full Text] [Related]
49. Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?
Dahlbäck B; Nielsen LB
Cell Mol Life Sci; 2009 Feb; 66(4):559-64. PubMed ID: 19153651
[TBL] [Abstract][Full Text] [Related]
50. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.
Frej C; Linder A; Happonen KE; Taylor FB; Lupu F; Dahlbäck B
J Cell Mol Med; 2016 Jun; 20(6):1170-81. PubMed ID: 26990127
[TBL] [Abstract][Full Text] [Related]
51. Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles.
Liu M; Allegood J; Zhu X; Seo J; Gebre AK; Boudyguina E; Cheng D; Chuang CC; Shelness GS; Spiegel S; Parks JS
J Biol Chem; 2015 Mar; 290(12):7861-70. PubMed ID: 25627684
[TBL] [Abstract][Full Text] [Related]
52. Angiopoietin-1 and vascular endothelial growth factor regulation of leukocyte adhesion to endothelial cells: role of nuclear receptor-77.
Ismail H; Mofarrahi M; Echavarria R; Harel S; Verdin E; Lim HW; Jin ZG; Sun J; Zeng H; Hussain SN
Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1707-16. PubMed ID: 22628435
[TBL] [Abstract][Full Text] [Related]
53. Apolipoprotein M promotes mobilization of cellular cholesterol in vivo.
Elsøe S; Christoffersen C; Luchoomun J; Turner S; Nielsen LB
Biochim Biophys Acta; 2013 Jul; 1831(7):1287-92. PubMed ID: 24046869
[TBL] [Abstract][Full Text] [Related]
54. Hyperglycemia down-regulates apolipoprotein M expression in vivo and in vitro.
Zhang X; Jiang B; Luo G; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2007 Jul; 1771(7):879-82. PubMed ID: 17556016
[TBL] [Abstract][Full Text] [Related]
55. Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome.
He L; Wu P; Tan L; Le B; Du W; Shen T; Wu J; Xiang Z; Hu M
Lipids Health Dis; 2017 Sep; 16(1):167. PubMed ID: 28877724
[TBL] [Abstract][Full Text] [Related]
56. Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion.
Wolfrum C; Stoffel M
Cell Metab; 2006 Feb; 3(2):99-110. PubMed ID: 16459311
[TBL] [Abstract][Full Text] [Related]
57. Regulation of the apolipoprotein M signaling pathway: a review.
Cheng G; Zheng L
J Recept Signal Transduct Res; 2022 Jun; 42(3):285-292. PubMed ID: 34006168
[TBL] [Abstract][Full Text] [Related]
58. Orphan nuclear receptor Nur77 mediates fasting-induced hepatic fibroblast growth factor 21 expression.
Min AK; Bae KH; Jung YA; Choi YK; Kim MJ; Kim JH; Jeon JH; Kim JG; Lee IK; Park KG
Endocrinology; 2014 Aug; 155(8):2924-31. PubMed ID: 24885573
[TBL] [Abstract][Full Text] [Related]
59. Induction of hepatocyte-like cells from mouse embryonic stem cells by lentivirus-mediated constitutive expression of Foxa2/Hnf4a.
Liu T; Zhang S; Xiang D; Wang Y
J Cell Biochem; 2013 Nov; 114(11):2531-41. PubMed ID: 23744720
[TBL] [Abstract][Full Text] [Related]
60. Clinical significance of serum apolipoprotein M level.
Tanaka S; Okamoto Y
Clin Lab; 2011; 57(9-10):803-6. PubMed ID: 22029201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
